HealthCare Market Analysis

The global  oncology based  in-vivo  CRO market  is expected to reach USD 1.5 billion by 2025, according to a new report by Grand View Research, Inc. The use of Contract Research Organization (CRO) oncology services helps the manufacturers/sponsors to provide complete attention on the production capacity and at enhancing their in-house processes. Furthermore, the pressure from the increasing competition due to patent expirations, rapid growth of generics, and introduction of biosimilar equivalents are propelling the pharmaceutical companies to take the aid of such organizations. Hence, it can be predicted that the oncology based  in-vivo  CRO market may witness lucrative growth over the forecast period. Another factor propelling growth is the increasing incidence of cancer, and high failure rate of existing treatment options. According to statistics published by the World Health Organization (WHO), approximately 8.2 million deaths are recorded each year from cancer, which acc

The  anesthesia monitoring devices market  is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications. The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period. Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, m

The global  erythropoietin (EPO) drugs market  is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market. According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years. Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time requir

The global  western blotting market  is anticipated to reach a value of USD 958.4 millionby 2025, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of western blotting market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect  Borrelia burgdorferi  (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency. Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech co

The global  prostate cancer therapeutics market  is expected to reach USD 12.0 billion by 2025, according to a new report by Grand View Research, Inc. According to the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate cancer in their lifetime. As per Cancer Research, a government institute, in the UK, 46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died in 2014.  Supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and on time treatment and assists in deciding treatment regimens. In addition, major players including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson & Johnson are focusing on development of eff

The global  burn care market  is expected to reach USD 2.98 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of burn injuries is anticipated to fuel the demand for cost-effective treatment over the forecast period. The introduction of advanced treatment options such as reconstructive surgery and skin graft or bio membrane are expected to upsurge the demand for these products over the coming years. Favorable government initiatives such as reimbursement policies that cover almost 70% to 100% of the treatment cost, upsurge the adoption of advanced wound care products during the forecast period. In addition, government organizations including the World Health Organization (WHO) and nonprofit organizations like the American Burn Association (ABA) are contributing toward raising awareness amongst consumers, which is anticipated to contribute to the growth of the market. For instance, the WHO entered into a collaborative agreement with the

The global  weight management market  is expected to reach USD 442.3 billion by 2025, according to a new report by Grand View Research, Inc. Rising number of overweight and obese population coupled with rising popularity of various commercially available solutions is fueling the growth. Increasing initiatives undertaken by market players in collaboration with the government to raise awareness about the adverse impact on health due to obesity are further anticipated to drive the market demand. The overweight and obese population are more prone to chronic diseases including diabetes, hypertension, and orthopedic diseases. Thus, rising awareness about weight management techniques is driving the market growth. Thanks to westernization and urbanization, there is an increasing preference toward processed food as an alternative to home-cooked food. The increase in number of nuclear families coupled with a rise in the working population have fueled the demand for easily accessible &a

Global  Wearable Medical Device Market  is expected to reach USD 27.8 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of conditions such as obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the demand for wearable medical devices. Moreover, increasing health awareness is further expected to augment the demand for these devices.  Additionally, growing incidences of chronic conditions, such as diabetes, which require round-the-clock monitoring, are expected to increase the demand for wearable technology. Technological innovation is projected to be vital for growth of this industry over the forecast period. Smart watches, smart bands, and smart clothing are anticipated to be the key areas for development. Increasing penetration of smart cellular phones is expected to assist growth of this technology. However, patient privacy and security concerns along with complexity in engineering are expected to impede g

Global  liquid biopsies market  is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant challenges associated with conventional biopsies such as, high level of invasiveness, incompleteness of cancer information that is acquired, associated post-biopsy serious medical complications, and subsequent cost inclusions. A growing need for more advanced, efficient and accurate method which provides a holistic view of the tumor and metastasis is the prime factor fueling rapid development of liquid biopsies. The market has gained considerable traction in the past couple of years. A number of clinical research projects related to circulating tumor cells, and cell-free tumor DNA have been initiated in the latter half of the past decade. As a result, there are a number of ongoing clinical trials that are due to be completed between post 2017-18. It is expected that upon

The global  non-PVC IV bags market  is expected to reach USD 2.29 billion by 2025, according to a new report by Grand View Research, Inc. Globally, increasing demand for safer medical packaging and strict regulations against usage of PVC are the key factors anticipated to boost the demand for non-PVC alternatives. Extensive research and developments for novel alternatives are expected to fuel the growth further. As per the current market scenario, usage of non-PVC IV bags is limited to fields such as chemotherapy and parenteral nutrition. With the introduction of different types of alternatives such as ethylene vinyl acetate and polypropylene, PVC packaging is anticipated to be replaced by non-PVC alternatives. These materials can be used for specific purposes such as cold/frozen storage and customized mixtures. The non-PVC packaging market is expected to witness lucrative growth during the forecast period owing to the versatility of applications. Demand for non-PVC plastics